Patents Represented by Attorney Knobbe Martens Olson & Hear LLP
  • Patent number: 7563885
    Abstract: Compounds, compositions and methods are provided for modulating the expression of Tudor-SN. The compositions comprise oligonucleotides, targeted to nucleic acid encoding Tudor-SN. Methods of using these compounds for modulation of Tudor-SN expression and for diagnosis and treatment of diseases and conditions associated with expression of Tudor-SN are provided.
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: July 21, 2009
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Nicholas M. Dean, Ming-Yi Chiang, Kenneth W. Dobie